Literature DB >> 15896760

Alterations in alpha adrenoreceptor density and localization after mechanical left ventricular unloading with the Jarvik flowmaker left ventricular assist device.

Alina Grigore1, Brian Poindexter, William K Vaughn, Nancy Nussmeier, O H Frazier, John R Cooper, Igor D Gregoric, L Maximilian Buja, Roger J Bick.   

Abstract

Cardiac alpha one adrenoreceptors (alpha(1)AR) are known to mediate positive inotropism in human ventricular myocardium. In the early stages of heart failure, ventricular contractility is maintained by adrenergic stimulation, rennin-angiotensin activation, and other neurohormonal and cytokine system responses. As the disease progresses, however, these compensatory mechanisms cease to provide benefit; ventricular dilation and fibrosis occur and cardiac function deteriorates. When ventricular contractility becomes severely depressed and is no longer responsive to inotropic support, insertion of a left ventricular assist device (LVAD) may allow the left ventricle to rest, remodel, and recover some contractile function. Our previous work has demonstrated that the myocardium has the capacity to repair itself during a period of unloading, after which some patients are able to resume a normal lifestyle and no longer need a cardiac transplant.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15896760     DOI: 10.1016/j.healun.2004.03.005

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  6 in total

1.  Reversal of myocyte hypertrophy by ventricular unloading: cardiac improvement without adrenergic receptor up-regulation and relocalization.

Authors:  Pippa M Schnee; Naeema Shah; Marianne Bergheim; Brian J Poindexter; L Max Buja; Timothy J Myers; Branislav Radovancevic; O Howard Frazier; Roger J Bick
Journal:  MedGenMed       Date:  2006-05-16

Review 2.  Cardiac and neuroprotection regulated by α(1)-adrenergic receptor subtypes.

Authors:  Dianne M Perez; Van A Doze
Journal:  J Recept Signal Transduct Res       Date:  2011-02-21       Impact factor: 2.092

Review 3.  Molecular changes occurring during reverse remodelling following left ventricular assist device support.

Authors:  Emma J Birks; Robert S George
Journal:  J Cardiovasc Transl Res       Date:  2010-09-04       Impact factor: 4.132

4.  Novel proteins associated with human dilated cardiomyopathy: selective reduction in α(1A)-adrenergic receptors and increased desensitization proteins.

Authors:  Ting Shi; Christine S Moravec; Dianne M Perez
Journal:  J Recept Signal Transduct Res       Date:  2013-02-06       Impact factor: 2.092

5.  Heart failure reversal by ventricular unloading in patients with chronic cardiomyopathy: criteria for weaning from ventricular assist devices.

Authors:  Michael Dandel; Yuguo Weng; Henryk Siniawski; Alexander Stepanenko; Thomas Krabatsch; Evgenij Potapov; Hans B Lehmkuhl; Christoph Knosalla; Roland Hetzer
Journal:  Eur Heart J       Date:  2010-10-07       Impact factor: 29.983

6.  Cardiac and Vascular α1-Adrenoceptors in Congestive Heart Failure: A Systematic Review.

Authors:  Gizem Kaykı-Mutlu; Olga Papazisi; Meindert Palmen; A H Jan Danser; Martin C Michel; Ebru Arioglu-Inan
Journal:  Cells       Date:  2020-11-04       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.